Pneumonia

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial

Ceccato A, Cillóniz C, Ranzani OT, Menéndez R, Agustı́ C, Gabarrús A, Ferrer M, Sibila O, Niederman MS, Torres A

Jan 1, 2017

Pneumonia in 2016: towards better care

Torres A, Ranzani OT, Ferrer M

Dec 1, 2016

Prone position and VAP incidence in the PROSEVA trial: attention to the causal question when interpreting competing risk analysis

Ranzani OT, Bassi GL, Torres A

Dec 1, 2016

The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study

Ranzani OT, Forte DN, Forte AC, Mimica I, Forte WCN

May 1, 2016

Community-acquired pneumonia

Prina E, Ranzani OT, Torres A

Sep 12, 2015

Importance of a registered and structured protocol when conducting systematic reviews: comments about nebulized antibiotics for ventilator-associated pneumonia

Zampieri FG, Nassar AP, Gusmao-Flores D, Taniguchi LU, Torres A, Ranzani OT

Aug 20, 2015

Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis

Zampieri FG, Nassar AP, Gusmao-Flores D, Taniguchi LU, Torres A, Ranzani OT

Apr 7, 2015

Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia

Prina E, Ranzani OT, Polverino E, Cillóniz C, Ferrer M, Fernández‐Barat L, Bellacasa JPdl, Menéndez R, Mensa J, Torres A

Feb 1, 2015

Gravity predominates over ventilatory pattern in the prevention of ventilator-associated pneumonia

Bassi GL, Martí JD, Saucedo LM, ..., Ranzani OT, ..., Vilà J, Torres A

Sep 1, 2014

Nosocomial pneumonia in the intensive care unit: how should treatment failure be predicted?

Ranzani OT, Prina E, Torres A

Jul 1, 2014